Continuous glucose monitoring (CGM) is a significant advance for diabetes management that, while standard of care for management of type 1 diabetes mellitus, is increasingly used for insulin-treated patients with type 2 diabetes mellitus [2–4]. The gene discussed is INS; the disease is diabetes mellitus.